PatrickDriscoll

I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses.Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.
Follow:
183 Articles

Global Size and Growth of Spine Surgery Market Segments

The worldwide market for technologies and products in spine surgery is over…

PatrickDriscoll PatrickDriscoll

Costs Associated with Spinal Disorders and Treatment

One of the most device-intensive areas of medical technology — one with…

PatrickDriscoll PatrickDriscoll

New Technologies at Medtech Startups, June 2011

Below is a list of the technologies under development at newly identified…

PatrickDriscoll PatrickDriscoll

Investment in Medtech Continues Upward Trend

Financings for medical technology during the month of June 2011 have passed…

PatrickDriscoll PatrickDriscoll

Push Accelerates for Artificial Pancreas for Type 1 Diabetes

By recently releasing guidelines for premarket approval and investigation device exemption of…

PatrickDriscoll PatrickDriscoll

Incidence and Prevalence of Morbid Obesity

Morbid obesity is associated with a substantially increased risk of morbidity and…

PatrickDriscoll PatrickDriscoll

Latin America: Markets in Advanced Wound Closure

In the Americas, the U.S. dominates all medtech markets, but as manufacturers…

PatrickDriscoll PatrickDriscoll

Surgical Sealants and Fibrin Glues

Surgical sealants and fibrin glues are biologically based products designed to aid…

PatrickDriscoll PatrickDriscoll

Worldwide Spine Surgery 2011: Products, Technologies, Markets & Opportunities, 2010-2020

Publishing in June, The MedMarket Diligence Report #M520, "Worldwide Spine Surgery 2011:…

PatrickDriscoll PatrickDriscoll

Obesity’s Outlook Unchanged

Drugs for the clinical treatment of obesity have taken hits over the…

PatrickDriscoll PatrickDriscoll